Best stocks to invest in
On Wednesday, November 9th, Mylan (MYL) will release its third quarter earnings results after the bell. The company is a Zacks Rank 4 (Sell), and have a Value, Growth, and Momentum score of C.
Dave will look at Mylan’s past earnings, take a look at what is currently going on with the company, and give us his thoughts on their upcoming earnings announcement.
Furthermore, Dave will uncover some potential options trades for investors looking to make a play on Mylan ahead of earnings.
Mylan in Focus
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.
Mylan is expected to report earnings at $1.51 a share according to the Zacks Consensus Estimate. Last quarter they beat earnings expectations by 0.87% at $1.16 per share, beating estimates of $1.15 a share.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
MYLAN NV (MYL): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
– Best stocks to invest in